INDEPENDENT VERDICT
Carlyle Phoenix SPV, L.P. is a newly disclosed 2025 Delaware private equity vehicle whose September 14, 2026 Form D can be connected directly to the broader Carlyle fund infrastructure through its Washington headquarters, TC Group general-partner entities, Carlyle personnel and placement-agent arrangements. The issuer is classified as a pooled private equity fund, relies on Rule 506(b) and Investment Company Act Section 3(c)(7), and offers pooled investment fund interests on an indefinite basis. At the time of filing, the first sale had not yet occurred, $0 had been reported sold and there were zero investors. That point is important because the filing documents the launch of an offering, not a completed fundraise. The SEC filing also identifies Jefferies LLC as sales-compensation recipient and estimates up to $1 million in sales commissions, distinguishing the primary Phoenix SPV from two related coinvestment vehicles filed the same day that reported no sales commissions.
ENTITY / GP PENETRATION
The legal chain is unusually clear. Carlyle Phoenix SPV, L.P. identifies TC Group Phoenix SPV, L.P. as its General Partner and TC Group Phoenix SPV, LLC as the General Partner of that GP. Jeremy Anderson, Robert Rosen and David Lobe are listed as authorized persons of the GP-level entity, while Robert Rosen signed the filing as Vice President of the GP of the GP. All of these entities and individuals use Carlyle's 1001 Pennsylvania Avenue, N.W., Suite 220 South address in Washington, D.C. David Lobe is independently identifiable on Carlyle's official website as a Managing Director in Legal and Compliance focused on fund formation and governance, further supporting the connection between the filing and Carlyle's institutional fund platform. Carlyle itself reports operating across 27 offices and managing approximately $474 billion across roughly 660 funds as of its current public corporate materials, but those are firmwide figures and must not be confused with the size of Phoenix SPV itself.
THREE-VEHICLE PHOENIX STRUCTURE
The strongest distinctive feature is that Carlyle did not file only one Phoenix entity. On September 14, 2026, three closely related private equity vehicles appeared in SEC records: Carlyle Phoenix SPV, L.P.; Carlyle Phoenix SPV Coinvestment, L.P.; and Carlyle Phoenix SPV Coinvestment-R, L.P. The main SPV and the standard Coinvestment vehicle both rely on Section 3(c)(7), while Coinvestment-R uses Section 3(c)(1). All three rely on Rule 506(b), all reported indefinite offering amounts, all showed $0 sold and zero investors, and all stated that the first sale had yet to occur. They also share the same Washington address and the same related-person group. This parallel architecture strongly suggests a transaction-specific sponsor / co-investment structure designed to accommodate different investor eligibility or allocation needs, although the Form D filings do not disclose the underlying portfolio company, transaction target or asset represented by the internal code name "Phoenix." FilingDossier therefore does not attribute Phoenix to any public Carlyle transaction without primary-source evidence.
PLACEMENT STRUCTURE AND ECONOMICS
The primary Phoenix SPV differs from the two coinvestment vehicles in one notable respect: Jefferies LLC is named as the sales-compensation recipient and associated broker-dealer, with CRD 2347, and the filing estimates $1 million of sales commissions. The two coinvestment vehicles, by contrast, report $0 sales commissions and no broker-dealer in Item 12. This difference may indicate that the main vehicle is being marketed through a placement channel while related co-invest vehicles are offered directly to selected investors or existing relationships, but the Form D alone does not confirm that interpretation. The filing also reports $0 in Item 16 payments to the disclosed related persons, which should not be interpreted as evidence that Carlyle charges no management fee, carried interest, transaction fee or fund expenses. Investors need the partnership agreement and subscription package to understand management economics, allocation of transaction fees, expense-sharing and whether economics differ between the main SPV and the two co-investment sleeves.
CORE RISKS AND DILIGENCE
The principal unresolved issue is the underlying investment. The SEC filing classifies Phoenix SPV as a private equity fund but gives no company name, sector, acquisition price, equity commitment, leverage level, expected holding period or target return. A transaction-specific SPV can create much higher concentration than a diversified flagship fund because investors may be exposed predominantly to one asset. Investors should therefore request the exact portfolio company or transaction, purchase price, equity capitalization, debt financing, entry valuation, ownership percentage, operating plan and exit assumptions. They should also compare the economics and investor eligibility of Carlyle Phoenix SPV, Carlyle Phoenix SPV Coinvestment and Coinvestment-R, determine why one vehicle uses Section 3(c)(1) while the others use Section 3(c)(7), and confirm whether Jefferies' estimated $1 million placement compensation is borne by Carlyle, the vehicle or investors. The Form D confirms a legitimate Carlyle-linked fund structure, but it does not provide enough information to assess the investment itself.
FINAL ASSESSMENT
Carlyle Phoenix SPV can be verified through a strong chain of SEC and official Carlyle evidence, but its investment thesis remains intentionally opaque in public records. The September 14, 2026 filing confirms a Delaware private equity SPV, TC Group Phoenix GP entities, Carlyle-associated personnel, Rule 506(b), Section 3(c)(7), Jefferies as placement agent and an indefinite offering with no first sale completed at filing. Two same-day coinvestment vehicles add a meaningful structural clue and make this filing more distinctive than a generic Carlyle fund notice. The critical research discipline is not to guess what "Phoenix" represents. Until Carlyle, a portfolio company or another authoritative filing identifies the underlying transaction, FilingDossier should treat Phoenix as an internal project or vehicle name only. For investors, the next step is transaction-level diligence: identify the asset, understand leverage and entry valuation, compare the three investment sleeves and verify fees, carry, allocation rights and exit mechanics before evaluating the opportunity.
SEC SNAPSHOT
Primary Issuer: Carlyle Phoenix SPV, L.P. CIK: 0002150137 SEC Form: Form D Accession No.: 0002150137-26-000001 File No.: 021-597329 Film No.: 261376187 Filing Date: September 14, 2026 Year Organized: 2025 Jurisdiction: Delaware Principal Address: 1001 Pennsylvania Avenue, N.W., Suite 220 South, Washington, DC 20004 Telephone: (771) 210-5884 Industry: Pooled Investment Fund Fund Classification: Private Equity Fund Investment Company Registered: No Investment Company Act Exclusion: Section 3(c)(7) Offering Exemption: Rule 506(b) Security Type: Pooled Investment Fund Interests Offering Amount: Indefinite Amount Sold: $0 Remaining: Indefinite First Sale: Yet to occur Investors: 0 Minimum Investment Reported: $0 Offering Expected Over One Year: No General Partner: TC Group Phoenix SPV, L.P. GP of GP: TC Group Phoenix SPV, LLC Related Persons: Jeremy Anderson; Robert Rosen; David Lobe Signer: Robert Rosen Signer Title: Vice President of the GP of the GP Placement Agent: Jefferies LLC Jefferies CRD: 2347 Estimated Sales Commissions: $1,000,000 Finder's Fees: $0 Item 16 Related-Person Payments: $0
RELATED PHOENIX VEHICLES
Carlyle Phoenix SPV Coinvestment, L.P. CIK: 0002150138 File No.: 021-597324 Filing Date: September 14, 2026 Fund Type: Private Equity Fund Offering Exemption: Rule 506(b) Investment Company Act Exclusion: Section 3(c)(7) Offering Amount: Indefinite Amount Sold: $0 Investors: 0 First Sale: Yet to occur Sales Commissions: $0
Carlyle Phoenix SPV Coinvestment-R, L.P. CIK: 0002149765 File No.: 021-597325 Filing Date: September 14, 2026 Fund Type: Private Equity Fund Offering Exemption: Rule 506(b) Investment Company Act Exclusion: Section 3(c)(1) Offering Amount: Indefinite Amount Sold: $0 Investors: 0 First Sale: Yet to occur Sales Commissions: $0
WEBSITE / ENTITY PENETRATION
Carlyle relationship strongly supported: YES Official Carlyle website confirmed: YES SEC / Carlyle Washington address relationship: YES TC Group Phoenix GP entities confirmed: YES Jeremy Anderson relationship confirmed in filing: YES Robert Rosen relationship confirmed in filing: YES David Lobe relationship confirmed in filing: YES David Lobe Carlyle official biography confirmed: YES Jefferies placement relationship confirmed: YES Three parallel Phoenix vehicles confirmed: YES Underlying portfolio company publicly confirmed: NO Underlying transaction value publicly confirmed: NO SPV target size publicly confirmed: NO Management fee publicly confirmed: NO Carried interest publicly confirmed: NO Acquisition leverage publicly confirmed: NO
CORE INVESTOR QUESTIONS
What company or asset does the internal "Phoenix" name represent What is the total equity commitment required for the transaction How much will the primary SPV raise What allocation goes to each coinvestment vehicle Why does Coinvestment-R use Section 3(c)(1) while the other vehicles use Section 3(c)(7) Who is eligible to invest in each sleeve What acquisition or investment leverage is being used What entry valuation and EBITDA multiple apply What management fee and carried interest are charged Are co-investors offered reduced or zero management fees or carry Who bears Jefferies' estimated $1 million sales compensation What expenses are allocated among the three vehicles What ownership percentage will Carlyle Phoenix investors hold What governance or information rights do SPV investors receive What is the anticipated exit route and holding period
PRIMARY EVIDENCE REVIEWED
SEC Form D for Carlyle Phoenix SPV, L.P., filed September 14, 2026. SEC Form D for Carlyle Phoenix SPV Coinvestment, L.P., filed September 14, 2026. SEC Form D for Carlyle Phoenix SPV Coinvestment-R, L.P., filed September 14, 2026. Carlyle official corporate website. Carlyle official David Lobe biography. SEC records identifying TC Group Phoenix SPV, L.P. and TC Group Phoenix SPV, LLC. SEC filing identifying Jefferies LLC as sales-compensation recipient for the primary vehicle. Public Carlyle materials used only for firm-level scale and organizational context.
IMPORTANT FORM D NOTICE
Form D is a notice of an exempt securities offering. It is not SEC approval of Carlyle Phoenix SPV, Carlyle, Jefferies or the unidentified underlying investment. The Form D filings report indefinite offering amounts, $0 sold and zero investors because the first sales had not yet occurred as of September 14, 2026. The name "Phoenix" should not be treated as proof of any particular acquisition, company or asset unless Carlyle or another authoritative primary source identifies that relationship. Investors should review the actual partnership documents, transaction materials, capitalization, leverage, fees and underlying asset before investing.